Free Trial
LON:CLSN

Calisen (CLSN) Share Price, News & Analysis

Calisen logo

About Calisen Stock (LON:CLSN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
260.80
260.80
52-Week Range
N/A
Volume
303,728 shs
Average Volume
311,693 shs
Market Capitalization
£1.43 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calisen and its competitors with MarketBeat's FREE daily newsletter.

CLSN Stock News Headlines

The 19 Best TV Shows Of 2023: Critics' Picks
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
30 Things About Shameless Only True Fans Knew
See More Headlines

CLSN Stock Analysis - Frequently Asked Questions

Shares of CLSN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calisen investors own include Kinross Gold (KGC), Allegro MicroSystems (ALGM), Anavex Life Sciences (AVXL), Bristol Myers Squibb (BMY), Corbus Pharmaceuticals (CRBP), Dynavax Technologies (DVAX) and Enterprise Products Partners (EPD).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Electrical Equipment & Parts
Sub-Industry
N/A
Current Symbol
LON:CLSN
CIK
N/A
Fax
N/A
Employees
1,748
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
90.97
Current Ratio
1.17
Quick Ratio
1.11

Sales & Book Value

Annual Sales
£248.10 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
12.48
Book Value
GBX 141.70 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
547,981,000
Free Float
N/A
Market Cap
£1.43 billion
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:CLSN) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners